Sessions
Revolutionising Supply & Value Chain Automation & Orchestration
Defining Automation & Building a Strategic Approach to Adoption at the Earliest Stages
Revolutionising Supply & Value Chain Automation & Orchestration
13:30am Chair Introduction
Chairperson: Ben Weil, Director of Manufacturing, INmune Bio
13:35am Presentation: The Value of Automation in CAR T Cell Manufacturing
- How can automation reduce the cost of manufacturing?
- Automation can reduce operator interventions and batch failure rates.
- Product quality and consistency can be improved through automation.
John Garcia, PhD, Head of New Manufacturing Technologies, UCL
13:50am Presentation: Orchestrate, integrate, innovate.
- Different options for orchestration at each phase of development, from first in human through to commercialization.
- What to consider when building a robust supply chain network.
- What’s next for orchestration in the cell and gene industry?
Matthew Lakelin, Vice President, Scientific Affairs & Product Development, Co-Founder, TrakCel
14:05am Presentation: Decentralized Manufacturing Orchestration
- How decentralized manufacturing works
- Orchestration in one platform
- Opportunities and challenges
Renato Panza, Digital Strategy Director, Galapagos
14:20am Presentation: The New Wave of Precision Medicine: Value Chain Strategies You Can’t Afford to Not Use
- Implementing automation in the supply chain in tandem with human expertise necessary for critical decision-making
- Bringing orchestration and automation into the pharma supply chain to improve efficiency and increase visibility
- Orchestrating the clinical supply chain with consideration for data integration, security, and compliance
Vesna Stamenkovic, Global Vaccine Strategy Lead, Marken
14:35pm Closing Panel with Q&A
With all session participants